New aspects of nanopharmaceutical delivery systems

Journal of Nanoscience and Nanotechnology

Volumn 8, Issue 5, 2008, Pages 2216-2229

  Marcato, Priscyla D ^a   Durán, Nelson ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Market; Nanobiotechnology; Nanopharmaceutical carrier systems; Nanostructures

Indexed keywords

(PEGYLATED) LIPOSOMES; BIOLOGICAL MOLECULES; BODY DISTRIBUTIONS; CARRIER SYSTEMS; DELIVERY SYSTEMS; FUNCTIONALIZED NANOPARTICLES (FNP); METALLIC NANOPARTICLES (MNP); MOLECULAR LEVELS; MULTIDISCIPLINARY FIELD; NANOSCALED; PHARMACEUTICAL DELIVERY; PHARMACEUTICAL TECHNOLOGIES; PHYSICO-CHEMICAL PROPERTIES; POLYMERIC NANOPARTICLES (NP); RECOMBINANT PROTEINS; SIDE EFFECTS; SOLID LIPID NANOPARTICLES (SLNS); SPECIFIC SITES;

AMINES; BIOLOGICAL SYSTEMS; BIOMOLECULES; CHEMICALS; CIVIL AVIATION; COLLOIDS; CYCLODEXTRINS; DENDRIMERS; DRUG PRODUCTS; LEAD; LIPIDS; LIPOSOMES; MOLECULES; NANOPARTICLES; NANOSTRUCTURES; NUCLEIC ACIDS; PHOSPHOLIPIDS; PROTEINS; TECHNOLOGY;

NANOSTRUCTURED MATERIALS;

DRUG DELIVERY SYSTEM; HUMAN; NANOTECHNOLOGY; REVIEW;

DRUG DELIVERY SYSTEMS; HUMANS; NANOTECHNOLOGY;

EID: 45849132429     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2008.274     Document Type: Article

References (125)

1. C. R. Martin and P. Kohli, Nat. Rev. Drug Discov. 2, 29 (2004).
2. O. Kayser, A. Lemke, and N. Hernandez-Trejo, Curr. Pharm. Biotechnol. 6, 3 (2005).
3. J. K. Vasir, M. K. Reddy, and V. D. Labhasetwar, Curr. Nanosci. 1, 45 (2005).
4. E. Bekyarova, Y. Ni, E. B. Malaekey, R. C. Montana, J. L. McWilliams, R. C. Haddon, and V. Parpura, J. Biomed. Nanotechnol. 1, 3 (2005).
5. J. Kim, J. W. Grate, and P. Wang, Chem. Eng. Sci. 61, 1017 (2006).
6. M. Rawat, D. Singh, and S. Saraf, Biol. Pharm. Bull. 29, 1790 (2006).
7. W. Vine, K. Gao, J. L. Zegelman, and S. K. Helsel, Drug Deliv. Technol. 5, 34 (2006).
8. A. A. Date, B. Naik, and M. S. Hagarsenker, Skin Pharmacol. Physiol. 19, 2 (2006).
9. L. Jia, H. Wong, C. Cerna, and D. Weitman, Pharm. Res. 19, 1091 (2002).
10. L. Brannon-Peppas and J. O. Blanchette, Adv. Drug Deliv. Rev. 56, 1649 (2004).
11. A. Gessner, C. Olbrich, W. Schröder, O. Kayser, and R. H. Müller, Int. J. Pharm. 214, 87 (2001).
12. J. Kreuter, Adv. Drug Deliv. Rev. 47, 65 (2001).
13. Nanotech Rx. Medical Applications of Nano-Scale Technologies: What Impact on Marginalized Communities? ETC-Group, September (2006).
14. N. N. Gaber, Y. Darwis, K. K. Peh, and Y. T. F. Tan, J. Nanosci. Nanotechnol. 6, 3095 (2006).
15. R. Savic, A. Eisenberg, and D. Maysinger, J. Drug Target. 14, 343 (2006).
16. O. M. Y. Koo, I. Rubinstein, and H. Onyuksel, J. Nanosci. Nanotechnol. 6, 2996 (2006).
17. J. Myschk, D. G. Lendemans, W. T. McBurney, P. H. Demana, S. Hook, and T. Rades, Micron 37, 724 (2006).
18. K. Osada and K. Kataoka, Adv. Polym. Sci. 202, 113 (2006).
19. O. V. Salata, J. Nanobiotechol. 2, 1 (2004).
20. J. M. Koziara, P. R. Lockman, D. D. Allen, and R. J. Mumper, J. Nanosci. Nanotechnol. 6, 2712 (2006).
21. M. R. Mozafari, Cell Mol. Biol. Lett. 10, 711 (2005).
22. A. Fahr, P. van Hoogevest, S. May, N. Bergstrand, and M. L. S. Leigh, Eur. J. Pharm. Sci. 26, 251 (2005).
23. J. H. Fang, T. L. Hwang, and Y. L. Huang, Curr. Nanosci. 2, 55 (2006).
24. Y. Kaneda and Y. Tabata, Cancer Sci. 97, 348 (2006).
25. L. Harris, G. Batist, R. Belt, D. Rovira, R. Navari, N. Azarnia, L. Welles, and E. Winer, Cancer 94, 25 (2002).
26. S. Ramachandran, A. P. Quist, S. Kumar, and R. Lal, Langmuir 22, 8156 (2006).
27. T. M. Allen and P. R. Cullis, Science 303, 1818 (2004).
28. http://www.covalon.com/News_Releases/news04260601.aspx, access 20 October 2007.
29. http://www.fda.gov/cder/da/da.htm, access 18 November 2006.
30. D. D. Von Hoff, Oncology Issue 17, 38 (2002).
31. htpp://www.antigenics.com, access 18 November 2006.
32. P. B. Malafaya, G. A. Silva, E. T. Baran, and R. L. Rei, Curr. Opin. Solid State Mater. Sci. 6, 283 (2002).
33. htpp://www.vical.com/products, access 18 November 2006.
34. htpp://www.nidr.nih.gov/research/cariesvaccine 01283003.asp, access 18 November 2006.
35. J. Bates, J. Ackland, A. Coulter, J. Cox, D. Drane, R. Macfarlan, J. Varigos, T.-Y. Wong, and W. Woods, Options for the Control of Influenza III, edited by L. E. Brown, A. W. Hampson, and R. G. Webster, Elsevier Science BV, Amsterdam (1996), pp. 661-667.
36. P. O. Livingston, S. Adluri, F. Helling, T.-J. Yao, C. R. Kensilt, M. J. Newman, and D. Marciani, Vaccine 12, 1275 (1994).
37. C. R. Kensil, Crit. Rev. Ther. Drug Carrier Syst. 13, 1 (1996).
38. G. F. A. Kersten and D. J. A. Crommelin, Vaccine 21, 915 (2003).
39. M. Singh and D. T. O'Hagan, Pharm. Res. 6, 715 (2002).
40. I. G. Barr, A. Sjölander, and J. C. Cox, Adv. Drug Deliv. Rev. 32, 247 (1998).
41. R. C. S. Rao, M. S. Kumar, N. Mathivanan, and M. E. B. Rao, Pharmazie 59, 5 (2004).
42. D. Quintanar-Guerrero, D. Tamayo-Esquivel, A. Ganem-Quintanar, E. Allemann, and E. Doelker, Eur. J. Pharm. Sci. 26, 211 (2005).
43. K. Manjunath, J. S. Reddy, and V. Venkateswarlu, Exper. Clin. Pharmacol. 27, 127 (2005).
44. V. S. Shenoy, I. K. Vijay, and R. S. R. Murthy, J. Pharm. Pharmacol. 57, 411 (2005).
45. S. A. Wissing, O. Kayser, and R. H. Müller, Adv. Drug Deliv. Rev. 56, 1257 (2004).
46. C. Schwarz and W. Mehnert, J. Microencapsul. 16, 205 (1999).
47. J. Kipp, Int. J. Pharm. 284, 109 (2004).
48. R. Pandey, S. Sharma, and G. K. Khuller, Tuberculosis 85, 415 (2005).
49. A. Fundaro, R. Cavalli, A. Bargoni, D. Vighetto, G. P. Zara, and M. R. Gaseo, Pharmacol. Res. 42, 337 (2000).
50. C. S. Maia, W. Mehnert, and M. Schäfer-Korting, Int. J. Pharm. 196, 165 (2000).
51. A. Dingler, R. P. Blum, H. Niehus, R. H. Müller, and S. Gohla, J. Microencapsul. 16, 751 (1999).
52. J. M. Harris and R. B. Chess, Nature Rev. Drug Discov. 2, 214 (2003).
53. K. Tabatt, M. Sameti, C. Olbrich, R. H. Müller, and C. M. Lehr, Eur. J. Pharm. Biopharm. 157, 155 (2004).
54. K. Tabatt, C. Kneuer, M. Sameti, C. Olbrich, R. H. Müller, C. M. Lehr, and U. Bakowsky, J. Control. Release 97, 321 (2004).
55. M. Kalariya, B. K. Padhi, M. Chougule, and A. Misra, Drug Deliv. Technol. 4, 1 (2004).
56. K. S. Soppimath, T. M. Aminabhavi, A. R. Kulkarni, and W. E. Rudzinski, J. Control. Release 70, 1 (2001).
57. E. Fattal, C. Vauthier, I. Aynie, Y. Nakada, G. Lambert, C. Malvy, and P. Couvreur, J. Control. Release 53, 137 (1998).
58. R. Fernandez-Urrusuno, P. Calvo, C. Remunan-Lopez, J. L. Vila-Jato, and M. J. Alonso, Pharm. Res. 16, 1576 (1999).
59. C. A. Farrugia and M. J. Groves, Anticancer Res. 19, 1027 (1999).
60. C. A. Farrugia and M. J. Groves, J. Pharm. Pharmacol. 51, 643 (1999).
61. I. Aynie, C. Vauthier, H. Chacun, E. Fattal, and P. Couvreur, Antisense Nucleic Acid Drug Dev. 9, 301 (1999).
62. S. S. Feng, Expert Rev. Med. Device 1, 115 (2004).
63. K. K. Jain, Drug Discov. Today 10, 1435 (2005).
64. S. R. Schaffazick, S. S. U. Guterres, L. D. Freitas, and A. R. Pohlmann, Quim. Nova 26, 726 (2003).
65. S. R. Schaffazick, A. R. Polhmann, G. Mezzalira, and S. S. Guterres, J. Brazilian Chem. Soc. 17, 562 (2006).
66. L. Cruz, S. R. Schaffazick, T. Dala Costa, L. U. Soares, G. Mezzalira, N. P. Da Silveira, E. E. S. Schapoval, A. R. Polhmann, and S. S. Guterres, J. Nanosci. Nanotechnol. 6, 3154 (2006).
67. M. Koping-Hoggard, A. Sanchez, and M. J. Alonso, Expert Rev. Vaccines 4, 185 (2005).
68. M. S. Lesniak and H. Brem, Nature Rev. Drug Discov. 3, 499 (2004).
69. C. P. Reis, R. J. Neufeld, A. J. Ribeiro, and F. Veiga, Nanomedicine: Nanotechnol. Biol. Med. 2, 8 (2006).
70. R. Duncan, Nature Rev. Drug Discov. 2, 347 (2003).
71. M. C. Garnett and P. Kallinteri, Occupational Med. 56, 307 (2006).
72. http://www.the-infoshop.com/study/fs21939_adhesive_bandages.html, access 18 November 2006.
73. R. D'Aquino, T. Harper, and C. R. Vas, Chem. Eng. Progr. 102, 35 (2006).
74. R. Duncan, Biochem. Soc. Trans. 35, 56 (2007).
75. N. Durán, A. F. De Oliveira, and M. M. M. De Azevedo, J. Chemother. 18, 73 (2006).
76. A. O. De Souza, F. P. Hemerly, L. Gomes-Cardoso, R. M. Santa-Rita, L. L. Leon, S. L. De Castro, and N. Durán, J. Chemother. 16, 530 (2004).
77. F. T. M. Costa, S. C. P. Lopes, P. A. Nogueira, G. Z. Justo, and N. Durán, Brazilian Patent PIBr, 056399-0 (2005).
78. L. L. Leon, C. C. Miranda, A. O. De Souza, and N. Durán, J. Antimicrob. Chemother. 48, 449 (2001).
79. U. Bilati, E. Allemann, and E. Doelker, Drug Deliver. Technol. 5, 1 (2005).
80. R. Russell, Pharm. Technol. 2, 17 (2003).
81. V. S. Nande, U. V Barabde, D. M. Morkhade, A. T. Patil, and S. B. Joshi, Reac. Funct. Polym. 66, 1373 (2006).
82. S. Drotleff, U. Lungwitz, M. Breunig, A. Dennis, T. Blunk, J. Tessmar, and A. Gopferich, Eur. J. Pharm. Biopharm. 58, 385 (2004).
83. J. W. Park, Breast Cancer Res. A, 93 (2002).
84. M. Sedlak, Coll. Czech. Chem. Commun. 70, 269 (2005).
85. Y. Y. Huang, T. W. Chung, and T. Tzeng, Int. J. Pharm. 156, 9 (1997).
86. www.fonendo.com, access 18 November 2006.
87. M. R. Mozafari, Nanocarrier Technologies: Frontier of Nanotherapy, Springer, USA (2006).
88. M. R. Mozafari and S. M. Mortazani, Nanoliposomes: From Fundamentals to Recent Development, Trafford Publ USA (2005).
89. M. R. Mozafari, J. Flanagan, L. Matia-Merino, A. Awati, A. Omri. Z. E. Suntrez, and H. Singh, J. Sci. Food Agric. 86, 2038 (2006).
90. D. Peer and R. Margalit, Neoplasia 6, 343 (2004).
91. B. E. Rabinow, Nature Rev. Drug Discov. 3, 785 (2004).
92. R. H. Müller, C. Jacobs, and O. Kayser, Adv. Drug Deliv. Rev. 47, 3 (2001).
93. E. Merisko-Liversidge, G. G. Liversidge, and E. R. Cooper, Eur. J. Pharm. Sci. 18, 113 (2003).
94. M. Sarkari, J. Brown, X. Chen, S. Swinnea, R. O. Williams, 3rd, and K. P. Johnston, Int. J. Pharm. 243, 17 (2002).
95. D. Myshko, Pharmavoice 34, 1 (2004).
96. S. H. Pun, F. Tack, N. C. Bellocq, J. Cheng, B. H. Grubbs, G. S. Jensen, M. E. Davis, M. Brewster, M. Janicot, B. Janssens, W. Floren, and A. Bakker, Cancer Biol. Ther. 3, 641 (2004).
97. P. M. Melo, G. Z. Justo, M. B. M. De Azevedo, N. Durán, and M. Haun, Toxicology 186, 217 (2003).
98. D. H. A. Correa, P. S. Melo, C. A. A. De Carvalho, M. B. M. De Azevedo, N. Durán, and M. Haun, Eur. J. Pharm. 510, 17 (2005).
99. M. B. M. De Azevedo, J. Alderete, J. A. Rodriguez, A. O. De Souza, A. Faljoni-Alario, and N. Durán, J. Inclusion Phenom. Mol. Recognit. Chem. 37, 93 (2000).
100. I. F. Gimenez, M. C. Anazetti, P. S. Melo, M. Haun, M. M. M. De Azevedo, N. Durán, and O. L. Alve, J. Biomed. Nanotechnol. 1, 352 (2005).
101. S. Stevenson and D. A. Tomalin, Adv. Drug Deliv. Rev. 57, 2106 (2005).
102. A. S. Goldstein, J. K. Amory, S. M. Martin, C. Vernon. A. Matsumoto, and P. Yager, Bioorg. Med. Chem. 9, 2819 (2001).
103. D. Pantarotto, C. D. Partidos, J. Hoebeke, F. Brown, E. Kramer. J. Briand, S. Muller, M. Prato, and A. Bianco, Chem. Biol. 10, 961 (2003).
104. H. Li, D. Q. Wang, B. L. Liu, and L. Z. Gao, Colloids Surf. B: Biointerfaces 33, 85 (2004).
105. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B. F. Erlanger, P. Seta, and C. Larroque, Biochem. Biophys. Res. Commun. 294, 116 (2002).
106. T. Lin, V. Bajpai, T. Ji, and L. Dai, Aust. J. Chem. 56, 635 (2003).
107. E. Katz and I. Willner, Angew. Chem. Int. Ed. 43, 6042 (2004).
108. W. R. Glomm, J. Disper. Sci. Technol. 26, 389 (2005).
109. N. Durán, P. D. Marcato, O. L. Alves, G. I. H. D. Souza, and E. Esposito, J. Nanobiotechnol. 3, 1 (2005).
110. M. Gericke and A. Pinches, Hydrometallurgy 83, 132 (2006).
111. D. Mandal, M. E. Bolander, D. Mukhopadhyay, G. Sarkar, and P Mukherjee, Appl. Microbiol. Biotechnol. 69, 485 (2006).
112. N. Vigneshwaran, A. A. Kathe, P. V Varadarajan, R. P. Nachane, and R. H. Balasubramanya, Colloids Surf. B-Biointerfaces 53, 55 (2006).
113. P. Li, J. Li, S. Wu, Q. Wu, and J. Li, Nanotechnology 16, 1912 (2005).
114. N. Durán, P. D. Marcato, G. I. H. De Souza, O. L. Alves, and E. Esposito, J. Biomed. Nanotechnol. 203, 1 (2007).
115. H. Gu, P. L. Ho, E. Tong, L. Wang, and B. Xu, Nano Lett. 3, 1261 (2003).
116. H. Gu, P. L. Ho, K. W. T. Tsang, C. H. Yu, and B. Xu, Chem. Commun. 15, 1966 (2003).
117. K.-C. Ho, P.-J. Tsai, Y.-S Lin, and Y.-C. Chen, Anal. Chem. 76, 7162 (2004).
118. J. P. Ehrenberg and S. K. Ault, BMC Public Health (2005), Vol. 5, p. 119.
119. A. R. Renslo and J. H. McKerrow, Nature Chem. Biol. 2, 701 (2006).
120. A. A. Date, M. D. Joshi, and V. B. Patravale, Adv. Drug Rev. (2007).
121. F. Frezard, D. A. Schettini, O. G. F. Rocha, and C. Demicheli, Quim. Nova 28, 511 (2005).
122. N. Durán, M. A. Alvarenga, P. S. Melo, and P. D. Marcato, J. Pharm. Pharmacol. (2008), submitted.
123. O. Kayser and A. F. Kiderlen, Exp. Opinion Invest. Drugs. 12, 197 (2003).
124. A. F. Oliveira, M. H. A. Santana, and M. I. Rê, Drying Technol. 24, 373 (2006).
125. S. K. Sahoo, S. Parveen, and J. J. Panda, Nanomedicine: Nanotechnol. Biol. Med. 3, 20 (2007).